Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Thoma Bravo to take Dayforce private

Reuters on MSN · 12h
Dayforce to go private in $12.3 billion Thoma Bravo acquisition
By Milana Vinn (Reuters) -Private equity firm Thoma Bravo has agreed to buy human resources software provider Dayforce for $12.3 billion, including debt, in a take-private deal that executives hope will help expand on the company's AI capabilities.
SiliconANGLE · 16h
Thoma Bravo to take HR software provider Dayforce private for $12.3B
Dayforce Inc. today announced that it has agreed to be acquired by private equity firm Thoma Bravo for $12.3 billion.
Markets Insider · 1d
Dayforce Enters into US$12.3 Billion Definitive Agreement with Thoma Bravo to Become a Private Company
Dayforce Stockholders to Receive US$70 Per Share in Cash, a 32% Premium to the Unaffected Share PriceTransaction Aims to Accelerate Dayforce’s
3don MSN

Dayforce stock: why going private may be the answer for the HR software firm

Dayforce stock jumps 30% as Thoma Bravo explores potential acquisition, signaling growth and private market opportunity.
16hon MSN

Goldman Sachs pledges $6B debt package for Thoma Bravo's Dayforce takeover - report

Goldman Sachs (NYSE:GS) has lined up a $6B debt financing package to back private equity firm Thoma Bravo's acquisition of HR ...
3d

Private Equity Powerhouse Eyes Dayforce in Billion-Dollar Deal

Private equity giant Thoma Bravo is reportedly circling Dayforce, a $1.76B cloud HCM leader, in what could be a landmark deal ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy